The global cardiovascular devices market, valued at US$ 72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, reaching US$ 77.71 billion in 2024 and an impressive US$ 110.39 billion by 2029. The growth of the cardiovascular devices market is primarily due to the increasing prevalence of CVD, the aging population, and the growing prevalence of...

 Drug Screening market in terms of revenue was estimated to be worth $9.1 billion in 2024 and is poised to reach $19.5 billion by 2029, growing at a CAGR of 16.6% from 2024 to 2029 according to a latest report published by MarketsandMarkets™. Growth in this market is attributed to the increasing drug & alcohol consumption and the implementation of stringent laws mandating...

In the near future, the Immunohistochemistry (IHC) industry is poised to undergo transformative advancements that will redefine diagnostic and research capabilities in the field of pathology and biology. With ongoing developments in antibody technology, automation, and image analysis, IHC techniques will become more precise, efficient, and accessible. Personalized medicine will benefit from...

The human microbiome industry is projected to continue to grow at an exponential rate in the near future. This is due to increasing public awareness of the importance of the microbiome and its potential to improve health. Research is continually discovering new ways to utilize the microbiome, such as through probiotics, prebiotics, and fecal transplants. Pharmaceutical companies are also...

The custom antibody market is poised for significant growth, projected to escalate from USD 579 million in 2024 to USD 901 million in 2029, boasting a robust CAGR of 9.2% during the forecast period. Driving factors include escalating demand for personalized medicines, a global upsurge in chronic diseases, and strides in genetic engineering. Dominated by key players like Thermo Fisher...

 X-Ray Detectors market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.2 billion by 2029, growing at a CAGR of 5.0% from 2023 to 2029 according to a latest report published by MarketsandMarkets™. The market's expansion can be credited to the escalating incidence of cardiovascular and neurovascular diseases, a surge in diagnostic and...

The global infection control market in terms of revenue was estimated to be worth $51.0 billion in 2024 and is poised to reach $69.2 billion by 2029, growing at a CAGR of 6.3% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key...

Lab Automation Market in terms of revenue was estimated to be worth $5.1 billion in 2022 and is poised to reach $7.1 Billion by 2028, growing at a CAGR of 5.8% from 2022 to 2028 according to a new report by MarketsandMarkets™. Factors such as increasing spending on pharmaceutical R&D, growing food safety concerns, and stringent regulatory control in healthcare...

The global GLP-1 analogues market is poised for substantial growth, projected to expand from USD 47.4 billion in 2024 to USD 471.1 billion by 2032, at a robust CAGR of 33.2%. Key drivers include the drugs' efficacy in managing diabetes and obesity, driving high demand and clinical research advancements. The market is dominated by two major players, Novo Nordisk...

Market Growth Outlook Summary The global AMD drugs market growth forecasted to transform from $10.46 billion in 2024 to $17.37 billion by 2029, driven by a CAGR of 10.7%. Factors such as the increase in the prevalence of AMD cases due to the changing lifestyle and dietary habits such as smoking, alcohol consumption, and lack of physical activity, a growing focus on research and development...